We are live on
!
Find out more
IC
Intersect Capital Portfolio holdings
AUM
$331M
1-Year Est. Return
6.79%
This Fund
S&P 500
This Quarter
Est. Return
+9.11%
1 Year Est. Return
-6.79%
3 Year Est. Return
+57.23%
5 Year Est. Return
+88.96%
10 Year Est. Return
–
AUM
$566M
AUM Growth
+$71.7M
(+15%)
Cap. Flow
+$32.4M
Cap. Flow
% of AUM
5.73%
Top 10 Holdings %
Top 10 Hldgs %
37.87%
Holding
384
New
48
Increased
214
Reduced
85
Closed
9
Avg Time Held Equity + Options
7.6
quarters
Top 10 Avg Time Held Equity + Options
13.3
quarters
Top 20 Avg Time Held Equity + Options
14.2
quarters
Avg Time Held Equity only
7.7
quarters
Top 10 Avg Time Held Equity only
13.3
quarters
Top 20 Avg Time Held Equity only
14.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
U.S. Targeted Value Portfolio ETF Class Shares
DFAT
|
+$10.6M |
| 2 |
Amazon
AMZN
|
+$1.2M |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$1.02M |
| 4 |
Global X Lithium & Battery Tech ETF
LIT
|
+$938K |
| 5 |
Apple
AAPL
|
+$603K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.6M |
| 2 |
AT&T
T
|
+$1.03M |
| 3 |
SPDR Gold Trust
GLD
|
+$355K |
| 4 |
Kimberly-Clark
KMB
|
+$338K |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$326K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.51% |
| 2 | Technology | 22.54% |
| 3 | Consumer Discretionary | 7.58% |
| 4 | Healthcare | 6.97% |
| 5 | Financials | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Valmont Industries
VMI
$8.99B
| $203K | 0.04% |
860
-3
| -0.3% | -$726 |
2021 Q1
1 quarter
|
|
|
SYKE
352
DELISTED
SYKES Enterprises Inc
SYKE
| $203K | 0.04% |
+3,776
| New | +$168K |
2021 Q2
0 quarters
|
|
353
Novo Nordisk
NVO
$169B
| $202K | 0.04% |
+4,834
| New | +$187K |
2021 Q2
0 quarters
|
|
354
Voya Financial
VOYA
$8.69B
| $202K | 0.04% |
3,292
-9
| -0.3% | -$591 |
2021 Q1
1 quarter
|
|
355
Gilead Sciences
GILD
$185B
| $200K | 0.04% |
+2,903
| New | +$194K |
2021 Q2
0 quarters
|
|
356
Usana Health Sciences
USNA
$281M
| $200K | 0.04% |
+1,957
| New | +$196K |
2021 Q2
0 quarters
|
|
357
The Gap Inc
GAP
$8.02B
| $200K | 0.04% |
+5,931
| New | +$196K |
2021 Q2
0 quarters
|
|
|
MCA
358
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
| $199K | 0.04% |
12,607
| – | – |
2020 Q4
2 quarters
|
|
359
Nuveen California Quality Municipal Income Fund
NAC
$1.56B
| $197K | 0.03% |
12,453
| – | – |
2020 Q4
2 quarters
|
|
360
Filana Therapeutics
FLNA
$35.9M
| $192K | 0.03% |
+2,252
| New | +$121K |
2021 Q2
0 quarters
|
|
|
QVCGA
361
DELISTED
QVC Group Inc Series A
QVCGA
| $191K | 0.03% |
+292
| New | +$187K |
2021 Q2
0 quarters
|
|
|
VEDL
362
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $175K | 0.03% |
12,316
-1,258
| -9% | -$17.6K |
2020 Q4
2 quarters
|
|
363
Summit Hotel Properties
INN
$669M
| $164K | 0.03% |
17,610
| – | – |
2020 Q2
4 quarters
|
|
364
Santander
BSBR
$43.1B
| $163K | 0.03% |
20,770
+5,180
| +33% | +$38.5K |
2020 Q4
2 quarters
|
|
365
DHT Holdings
DHT
$4.31B
| $160K | 0.03% |
24,665
+2,935
| +14% | +$18K |
2020 Q4
2 quarters
|
|
|
NBW
366
DELISTED
Neuberger Berman California Municipal Fund Inc.
NBW
| $160K | 0.03% |
11,000
| – | – |
2017 Q3
15 quarters
|
|
367
DELISTED
Marathon Oil Corporation
MRO
| $150K | 0.03% |
+11,033
| New | +$133K |
2021 Q2
0 quarters
|
|
368
GrafTech
EAF
$215M
| $131K | 0.02% |
+1,124
| New | +$141K |
2021 Q2
0 quarters
|
|
369
Definium Therapeutics
DFTX
$4.63B
| $112K | 0.02% |
+2,167
| New | +$114K |
2021 Q2
0 quarters
|
|
370
Nomura Holdings
NMR
$28.1B
| $104K | 0.02% |
20,401
-7,378
| -27% | -$39.7K |
2020 Q4
2 quarters
|
|
|
NDACU
371
DELISTED
NightDragon Acquisition Corp. SCALE Units
NDACU
| $101K | 0.02% |
10,000
| – | – |
2021 Q1
1 quarter
|
|
372
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $88K | 0.02% |
13,764
| – | – |
2020 Q1
5 quarters
|
|
373
Diversified Healthcare Trust
DHC
$1.84B
| $78K | 0.01% |
18,776
-12,470
| -40% | -$51.5K |
2020 Q4
2 quarters
|
|
374
Corbus Pharmaceuticals
CRBP
$95.4M
| $27K | ﹤0.01% |
484
| – | – |
2021 Q1
1 quarter
|
|
375
ChargePoint
CHPT
$196M
| $11K | ﹤0.01% |
+15
| New | +$7.94K |
2021 Q2
0 quarters
|
|
Similar funds
FPS
BWM
TF
CP
RIM
MWM
PPW
HA
Intersect Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Intersect Capital held 384 positions worth $566M, up 15% from $494M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Intersect Capital deployed $32.4M of net new capital in Q2 2021, opening 48 new positions and adding to 214 existing holdings. Its largest new stake was U.S. Targeted Value Portfolio ETF Class Shares: 234,865 shares worth $10.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 37% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $1.6M trimmed.
- Intersect Capital's largest Q2 2021 buy was U.S. Targeted Value Portfolio ETF Class Shares: 234,865 shares worth $10.5M.
- Intersect Capital added most to Amazon in Q2 2021, an estimated $1.2M increase.
- Intersect Capital's biggest Q2 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.6M.
- Intersect Capital fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $326K.
- Intersect Capital's ten largest holdings make up 38% of its $566M portfolio in Q2 2021.
- Intersect Capital opened 48 new positions and closed 9 in Q2 2021.
- Intersect Capital's portfolio value rose 15% quarter-over-quarter to $566M.
Based on Intersect Capital's 13F filing for Q2 2021, filed 10 Aug 2021.